AU2003243439A8 - Medical device for intra-lumenal delivery of pharmaceutical agents - Google Patents
Medical device for intra-lumenal delivery of pharmaceutical agentsInfo
- Publication number
- AU2003243439A8 AU2003243439A8 AU2003243439A AU2003243439A AU2003243439A8 AU 2003243439 A8 AU2003243439 A8 AU 2003243439A8 AU 2003243439 A AU2003243439 A AU 2003243439A AU 2003243439 A AU2003243439 A AU 2003243439A AU 2003243439 A8 AU2003243439 A8 AU 2003243439A8
- Authority
- AU
- Australia
- Prior art keywords
- lumenal
- intra
- delivery
- medical device
- pharmaceutical agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2271—Neuropeptide Y
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16605902A | 2002-06-10 | 2002-06-10 | |
US10/166,059 | 2002-06-10 | ||
PCT/US2003/018059 WO2003103743A2 (en) | 2002-06-10 | 2003-06-10 | Medical device for intra-lumenal delivery of pharmaceutical agents |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003243439A1 AU2003243439A1 (en) | 2003-12-22 |
AU2003243439A8 true AU2003243439A8 (en) | 2003-12-22 |
Family
ID=29732103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003243439A Abandoned AU2003243439A1 (en) | 2002-06-10 | 2003-06-10 | Medical device for intra-lumenal delivery of pharmaceutical agents |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1551334A4 (en) |
JP (1) | JP2005528956A (en) |
AU (1) | AU2003243439A1 (en) |
CA (1) | CA2489282A1 (en) |
WO (1) | WO2003103743A2 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7399480B2 (en) * | 1997-09-26 | 2008-07-15 | Abbott Laboratories | Methods of administering tetrazole-containing rapamycin analogs with other therapeutic substances using medical devices |
US7674222B2 (en) | 1999-08-09 | 2010-03-09 | Cardiokinetix, Inc. | Cardiac device and methods of use thereof |
US9694121B2 (en) | 1999-08-09 | 2017-07-04 | Cardiokinetix, Inc. | Systems and methods for improving cardiac function |
US8377114B2 (en) | 1999-08-09 | 2013-02-19 | Cardiokinetix, Inc. | Sealing and filling ventricular partitioning devices to improve cardiac function |
US8500795B2 (en) | 1999-08-09 | 2013-08-06 | Cardiokinetix, Inc. | Retrievable devices for improving cardiac function |
US10307147B2 (en) | 1999-08-09 | 2019-06-04 | Edwards Lifesciences Corporation | System for improving cardiac function by sealing a partitioning membrane within a ventricle |
US8529430B2 (en) | 2002-08-01 | 2013-09-10 | Cardiokinetix, Inc. | Therapeutic methods and devices following myocardial infarction |
US8257428B2 (en) | 1999-08-09 | 2012-09-04 | Cardiokinetix, Inc. | System for improving cardiac function |
US10064696B2 (en) | 2000-08-09 | 2018-09-04 | Edwards Lifesciences Corporation | Devices and methods for delivering an endocardial device |
US9332992B2 (en) | 2004-08-05 | 2016-05-10 | Cardiokinetix, Inc. | Method for making a laminar ventricular partitioning device |
US9332993B2 (en) | 2004-08-05 | 2016-05-10 | Cardiokinetix, Inc. | Devices and methods for delivering an endocardial device |
US9078660B2 (en) | 2000-08-09 | 2015-07-14 | Cardiokinetix, Inc. | Devices and methods for delivering an endocardial device |
WO2007130724A2 (en) | 2006-02-06 | 2007-11-15 | Northwind Ventures | Systems and methods for volume reduction |
US8404281B2 (en) | 2009-06-08 | 2013-03-26 | Avant Garde Therapeutics & Technologies Llc | Formulations |
WO2011056578A2 (en) | 2009-10-26 | 2011-05-12 | Cardiokinetix, Inc. | Ventricular volume reduction |
WO2011159899A1 (en) * | 2010-06-16 | 2011-12-22 | Avant Garde Therapeutics Inc. | Novel formulations and methods |
CN104066395B (en) * | 2011-12-15 | 2017-09-05 | 里兰斯坦福初级大学理事会 | Apparatus and method for treating pulmonary hypertension |
AU2015321690A1 (en) | 2014-09-28 | 2017-03-23 | Cardiokinetix, Inc. | Apparatuses for treating cardiac dysfunction |
DE102018107407A1 (en) | 2017-03-28 | 2018-10-04 | Edwards Lifesciences Corporation | POSITIONING, INSERTING AND RETRIEVING IMPLANTABLE DEVICES |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5603722A (en) * | 1995-06-06 | 1997-02-18 | Quanam Medical Corporation | Intravascular stent |
JP2003532757A (en) * | 2000-05-11 | 2003-11-05 | イーストマン ケミカル カンパニー | Acylated cyclodextrin: guest molecule inclusion complex |
US6613753B2 (en) * | 2001-02-21 | 2003-09-02 | Supergen, Inc. | Restore cancer-suppressing functions to neoplastic cells through DNA hypomethylation |
US20030134811A1 (en) * | 2001-10-09 | 2003-07-17 | John Jackson | Methods and compositions comprising hydroxyapatite useful for the administration of therapeutic agents |
-
2003
- 2003-06-10 CA CA002489282A patent/CA2489282A1/en not_active Abandoned
- 2003-06-10 WO PCT/US2003/018059 patent/WO2003103743A2/en not_active Application Discontinuation
- 2003-06-10 JP JP2004510861A patent/JP2005528956A/en active Pending
- 2003-06-10 AU AU2003243439A patent/AU2003243439A1/en not_active Abandoned
- 2003-06-10 EP EP03757429A patent/EP1551334A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2003103743A3 (en) | 2004-07-22 |
AU2003243439A1 (en) | 2003-12-22 |
EP1551334A2 (en) | 2005-07-13 |
EP1551334A4 (en) | 2006-12-13 |
WO2003103743A2 (en) | 2003-12-18 |
JP2005528956A (en) | 2005-09-29 |
CA2489282A1 (en) | 2003-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003297621A8 (en) | Medical devices for delivery of therapeutic agents | |
AU2003295614A8 (en) | Delivery of pharmaceutical agents via the human insulin receptor | |
GB0313604D0 (en) | Delivery device for powdered medicament | |
AU2003243439A8 (en) | Medical device for intra-lumenal delivery of pharmaceutical agents | |
EP1648327A4 (en) | Oral devices and methods for controlled drug delivery | |
AU2003299849A8 (en) | Drug delivery apparatus | |
AU2003286639A8 (en) | Mixing and delivery medical syringe system for therapeutic compositions | |
PL368207A1 (en) | Ophthalmic drug delivery device | |
AU2003243305A8 (en) | Implantable medication delivery device | |
AU2003251563A1 (en) | Implatable or insertable medical devices for controlled delivery of a therapeutic agent | |
EP1684669A4 (en) | Ophthalmic drug delivery device | |
HK1073997A1 (en) | Administration of agents for the treatment of inflammation | |
HUE040600T2 (en) | Device for drug delivery to animals | |
AU2003281810A1 (en) | Medical delivery device | |
GB2385273B (en) | Drug delivery device | |
AUPR553701A0 (en) | A device for the delivery of a drug to a fractured bone | |
AU2003231260A8 (en) | Catechin multimers as therapeutic drug delivery agents | |
IL149377A0 (en) | Pharmaceutical formulation comprising melatonin | |
AU2003250317A8 (en) | Device for administration of fluids | |
AU2003224316A8 (en) | Device for delivery of biologically active agents | |
ZA200603126B (en) | Pharmaceutical compositions for therapeutic use | |
GB0201607D0 (en) | Formulation for the administration of medicinal substances | |
GB0210020D0 (en) | Medical agent delivery | |
AU2003230034A8 (en) | Transdermal delivery device for the administration of fentanyl | |
ZA200605719B (en) | Device and method for administering therapeutic agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |